Takeda launches CINRYZE in India for hereditary angioedema patients
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
Subscribe To Our Newsletter & Stay Updated